SLCH Consortium Adult Congenital Heart Disease

Topics

• Cardiac Fibrosis and Remodeling 33
• Congenital Heart Disease Studies 20
• Cardiac Valve Diseases and Treatments 16
• Heart Failure Treatment and Management 15
• Cardiovascular Function and Risk Factors 11
• Mechanical Circulatory Support Devices 10
• Cardiac electrophysiology and arrhythmias 8
• Signaling Pathways in Disease 7
• Cardiac Ischemia and Reperfusion 6
• Cardiac Structural Anomalies and Repair 6
• Cardiovascular and Diving-Related Complications 6
• Adipose Tissue and Metabolism 5

Most cited

1. Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology.

   Journal of the American College of Cardiology · 2026 · 135 citations · Sumanth Prabhu

2. TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis.

   The Journal of clinical investigation · 2021 · 299 citations · Huie Lin

3. Structural basis for Cas9 off-target activity.

   Cell · 2022 · 166 citations · Huie Lin

4. Myocardial Inflammation in Heart Failure With Reduced and Preserved Ejection Fraction.

   Circulation research · 2024 · 62 citations · Sumanth Prabhu

5. Ultrathin ferroic HfO2-ZrO2 superlattice gate stack for advanced transistors.

   Nature · 2022 · 124 citations · Huie Lin

6. Neutrophils are indispensable for adverse cardiac remodeling in heart failure.

   Journal of molecular and cellular cardiology · 2024 · 50 citations · Sumanth Prabhu

7. Ponatinib Drives Cardiotoxicity by S100A8/A9-NLRP3-IL-1β Mediated Inflammation.